ALPHA TRIBE

Novartis India LtdImportant, 01-01-1970: Company Update

01-01-1970 | 12:00 am

Axis Capital Limited, CIN No.: U64990MH2005PLC157853; Website: www.axiscapital.co.in Registered Office: Axis House, 1st Floor, Pandurang Budhkar Marg, Worli, Mumbai - 400 025,

Tel. No.: +91-22-4325 1199; Fax: +91-22-4325 3000; SEBI Merchant Banker Reg. No.: INM000012029, SEBI Reg. No.: Stockbroker - INZ000189931; Research Analyst - INH000002434; Member of: BSE, NSE & MSEI

Compliance Officer - Ms. Vilma Mathias Gangahar; Email Address: acl.compliance@axiscap.in

June 18, 2026

BSE Limited

Phiroze Jeejeebhoy Towers,

Dalal Street,

Mumbai- 400001,

Maharashtra, India.

Dear Sir/ Madam,

Subject: Open offer for acquisition of up to 64,19,608 (sixty four lakhs nineteen thousand six hundred and eight)

fully paid-up equity shares of face value of INR 5 each (“Equity Shares”) from the Public Shareholders of

Novartis India Limited (“Target Company”), representing 26% of the ‘Voting Share Capital’ of the Target

Company by WaveRise Investments Limited (“Acquirer 1”), ChrysCapital Fund X, the first scheme of

䍨特獃慰椀瑡氠呲畳琀 䤀Ⱐ愠挀慴攀杯特 䥉 慬瑥牮慴椀癥 楮癥獴浥湴 晵渀搠牥杩獴攀牥搠睩瑨 瑨攀 匀散畲椀琀楥猠慮搀 䕸捨慮来 

Board of India (“Acquirer 2”) and Two Infinity Partners (“Acquirer 3”) (Acquirer 1, Acquirer 2, and

Acquirer 3, collectively referred to as the “Acquirers”) along with ChrysCapital X, LLC (“PAC 1”) and

OceanEdge Investments Limited (“PAC 2”) (PAC 1 and PAC 2, collectively referred to as the “PACs”), in

their capacity as persons acting in concert with the Acquirers (“Open Offer”). 

剥㨠 䑩獣氀潳畲攀映湵浢敲 潦⁅焀畩瑹⁓栀慲敳 瑥湤敲敤⁩渀⁣潮湥捴楯渠睩瑨 琀桥⁣慰瑩潮敤 佰敮 佦晥爮 

Please note that in relation to the Open Offer:

(i)NIL Equity Shares, constituting NIL% of the Offer Size, have been tendered till June 18, 2026 in the Open Offer

Escrow Demat Account namely “MIIPL NOVARTIS INDIA LIMITED OPEN OFFER ESCROW DEMAT

ACCOUNT” opened with Ventura Securities Limited bearing depository participant identification number

IN303116 and the client identification number 15855051 (PAN: AAACH2914F) (the “Open Offer Escrow

Demat Account”), as per Open Offer Escrow Demat Account statement received by the Manager to the Open

Offer from Ventura Securities Limited; and

(ii)10 Equity Shares, constituting 0.00% of the Offer Size, have been tendered till June 18, 2026 in the physical

form with the Registrar to the Open Offer, as per the email received by the Manager to the Open Offer from the

Registrar to the Open Offer.

It is hereby expressly clarified that the above disclosure reflects: (i) the Equity Shares in dematerialized form tendered by

the Public Shareholders in the Open Offer Escrow Demat Account as per the Open Offer Escrow Demat Account statement

received by the Manager to the Open Offer from Ventura Securities Limited; and (ii) physical Equity Shares received by

the Registrar to the Open Offer, communicated to the Manager to the Open Offer by the Registrar to the Open Offer via

email.

For avoidance of doubt, the Equity Shares tendered by the Public Shareholders shall be subject to validation and verification

of submission of the complete set of documents, as applicable. The Equity Shares “validly tendered” in the Open Offer

shall be accepted in accordance with the SEBI (SAST) Regulations and the Letter of Offer dated June 1, 2026 (“Letter

of Offer”). The aforementioned number of the Equity Shares tendered by the Public Shareholders may differ from

the number of the Equity Shares which will be accepted by the Acquirers in the Open Offer.

Capitalized terms used herein and not specifically defined shall have the same meaning as ascribed to them in the Letter of

Offer.

We request you to take the same on your records and upload it on your website for dissemination to the public.

Thanking You,

For and on behalf of Axis Capital Limited

_________________________________

Name: Pratik Pednekar

Designation: AVP

----------------Page (0) Break----------------

No comments yet. Be the first to comment!

All announcements from Novartis India Ltd